Div Health DHC Q1 2026 Results Fall Short EPS 018 Revenue NA Cerebras Systems IPO Draws Caution from Jim Cramer Amidst AI Chip Frenzy Cerebras Stock Slips 10 on First Full Trading Day After Blockbuster IPO Debut NanoViricides NNVC Q1 2026 Beat Revenue NA EPS Exceeds by Significant The Key Metric in an AI Companys Latest Earnings That Could Shift Investor Sentiment Futu Reports 25 Revenue Surge in Q1 2026 Driven by Strong Trading Activity RBI Rate Cut Dilutes Policy Framework Nomura Suggests Oil Prices Gain as Irans Nuclear Stance Heightens Geopolitical Tensions ConocoPhillips Shares Advance as Oil Prices Rebound Bajot Auto Shares Edge Higher as Dividend Record Date Nears Dole Q1 2026 Earnings EPS Misses Expectations by 34 Shares Edge Lower Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues CAE Q1 2026 Earnings EPS Beats Estimates Stock Drops Over 14 FBIO Q4 2025 Earnings Deep EPS Miss Highlights Challenges for PreRevenue Biotech TMC Q1 2026 Earnings PreRevenue Progress Overshadows NarrowerThanExpected Loss FOR Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Gains 36 Gores Holdings X GTEN Hovers Near 1034 as Mild Selling Pressure Keeps Stock Flat Phoenix Education Partners Inc PXED Narrow Price Movement Suggests Consolidation Near Support BCTXL Drops 1653 as Warrants Test Key Support at 085 Expand Energy EXE Edges Higher as Natural Gas Markets Show Signs of Stability Carlyle Credit Income Fund CCIF Dips 22 Key Support Levels in Focus The Pokmon Card Boom Nostalgia Speculation and MillionDollar Sales Attract Crypto Bros and Celebrities Zebra Technologies Deepens Industrial Automation Push with Strategic Investment in Apera AIs 4D Vision US Productivity Growth Decelerates in Q4 as Unit Labor Costs Rise WSJs Heard on the Street Launches Eighth Annual StockPicking Competition Pokmon Card Market Boom Nostalgia Speculation and Celebrity Influence Middle East Conflict Challenges Gulfs AI Hub Ambitions as Data Center Attacks and Energy Costs Rise Exodus Movement Inc EXOD Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable Amicus Therapeutics FOLD Holds Steady Near Support as Biotech Sector Waits for Catalyst